is glp-1 harmful Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Primer: The Skinny on GLP-1s
Description
Reminders for your refill will continue until your prescription expires
Where positive effects have been observed, the magnitude of weight loss is typically smallgenerally in the range of 0.5-2 kgwhich may not be clinically meaningful for most individuals seeking weight management
Ozempic (semaglutide) is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare providers discretion
Such reductions could prevent obesity-related conditions like type 2 diabetes
#Obesity #GLP1 #MASH #Biopharma #DrugDevelopment To view or add a comment, sign in Great post Alexis - bang on the money
